Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146849730> ?p ?o ?g. }
- W2146849730 endingPage "1251" @default.
- W2146849730 startingPage "1242" @default.
- W2146849730 abstract "Ten cytoselective compounds have been identified from 372 thiazolidinone analogues by applying iterative library approaches. These compounds selectively killed both non-small cell lung cancer cell line H460 and its paclitaxel-resistant variant H460 taxR at an IC 50 between 0.21 and 2.93 microM while showing much less toxicity to normal human fibroblasts at concentrations up to 195 microM. Structure-activity relationship studies revealed that (1) the nitrogen atom on the 4-thiazolidinone ring (ring B in Figure 1) cannot be substituted, (2) several substitutions on ring A are tolerated at various positions, and (3) the substitution on ring C is restricted to the -NMe 2 group at the 4-position. A pharmacophore derived from active molecules suggested that two hydrogen bond acceptors and three hydrophobic regions were common features. Activities against P-gp-overexpressing and paclitaxel-resistant cell line H460 taxR and modeling using a previously validated P-gp substrate pharmacophore suggested that active compounds were not likely P-gp substrates." @default.
- W2146849730 created "2016-06-24" @default.
- W2146849730 creator A5012216290 @default.
- W2146849730 creator A5031793941 @default.
- W2146849730 creator A5034128046 @default.
- W2146849730 creator A5042731828 @default.
- W2146849730 creator A5042743314 @default.
- W2146849730 creator A5042973046 @default.
- W2146849730 creator A5046386721 @default.
- W2146849730 creator A5046881277 @default.
- W2146849730 creator A5073973321 @default.
- W2146849730 creator A5085603919 @default.
- W2146849730 creator A5087198508 @default.
- W2146849730 creator A5090427268 @default.
- W2146849730 date "2008-02-08" @default.
- W2146849730 modified "2023-09-28" @default.
- W2146849730 title "Design, Synthesis, Cytoselective Toxicity, Structure–Activity Relationships, and Pharmacophore of Thiazolidinone Derivatives Targeting Drug-Resistant Lung Cancer Cells" @default.
- W2146849730 cites W1967627004 @default.
- W2146849730 cites W1973522717 @default.
- W2146849730 cites W1987684543 @default.
- W2146849730 cites W1994964799 @default.
- W2146849730 cites W1997241897 @default.
- W2146849730 cites W2006434892 @default.
- W2146849730 cites W2009351077 @default.
- W2146849730 cites W2014749456 @default.
- W2146849730 cites W2016460754 @default.
- W2146849730 cites W2017047552 @default.
- W2146849730 cites W2017289276 @default.
- W2146849730 cites W2019660336 @default.
- W2146849730 cites W2026029321 @default.
- W2146849730 cites W2028126678 @default.
- W2146849730 cites W2037621239 @default.
- W2146849730 cites W2041375482 @default.
- W2146849730 cites W2047483806 @default.
- W2146849730 cites W2051860091 @default.
- W2146849730 cites W2054393089 @default.
- W2146849730 cites W2058145453 @default.
- W2146849730 cites W2061794702 @default.
- W2146849730 cites W2095624641 @default.
- W2146849730 cites W2098373613 @default.
- W2146849730 cites W2098562674 @default.
- W2146849730 cites W2106415622 @default.
- W2146849730 cites W2109689528 @default.
- W2146849730 cites W2113504145 @default.
- W2146849730 cites W2135732933 @default.
- W2146849730 cites W2143219535 @default.
- W2146849730 cites W2150236342 @default.
- W2146849730 cites W2151881294 @default.
- W2146849730 cites W2155208683 @default.
- W2146849730 cites W2176196363 @default.
- W2146849730 cites W2750896950 @default.
- W2146849730 cites W2950485623 @default.
- W2146849730 cites W2951822317 @default.
- W2146849730 cites W2952210173 @default.
- W2146849730 cites W2953312077 @default.
- W2146849730 doi "https://doi.org/10.1021/jm7012024" @default.
- W2146849730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18257542" @default.
- W2146849730 hasPublicationYear "2008" @default.
- W2146849730 type Work @default.
- W2146849730 sameAs 2146849730 @default.
- W2146849730 citedByCount "151" @default.
- W2146849730 countsByYear W21468497302012 @default.
- W2146849730 countsByYear W21468497302013 @default.
- W2146849730 countsByYear W21468497302014 @default.
- W2146849730 countsByYear W21468497302015 @default.
- W2146849730 countsByYear W21468497302016 @default.
- W2146849730 countsByYear W21468497302017 @default.
- W2146849730 countsByYear W21468497302018 @default.
- W2146849730 countsByYear W21468497302019 @default.
- W2146849730 countsByYear W21468497302020 @default.
- W2146849730 countsByYear W21468497302021 @default.
- W2146849730 countsByYear W21468497302022 @default.
- W2146849730 countsByYear W21468497302023 @default.
- W2146849730 crossrefType "journal-article" @default.
- W2146849730 hasAuthorship W2146849730A5012216290 @default.
- W2146849730 hasAuthorship W2146849730A5031793941 @default.
- W2146849730 hasAuthorship W2146849730A5034128046 @default.
- W2146849730 hasAuthorship W2146849730A5042731828 @default.
- W2146849730 hasAuthorship W2146849730A5042743314 @default.
- W2146849730 hasAuthorship W2146849730A5042973046 @default.
- W2146849730 hasAuthorship W2146849730A5046386721 @default.
- W2146849730 hasAuthorship W2146849730A5046881277 @default.
- W2146849730 hasAuthorship W2146849730A5073973321 @default.
- W2146849730 hasAuthorship W2146849730A5085603919 @default.
- W2146849730 hasAuthorship W2146849730A5087198508 @default.
- W2146849730 hasAuthorship W2146849730A5090427268 @default.
- W2146849730 hasConcept C112887158 @default.
- W2146849730 hasConcept C121608353 @default.
- W2146849730 hasConcept C126322002 @default.
- W2146849730 hasConcept C164126121 @default.
- W2146849730 hasConcept C178790620 @default.
- W2146849730 hasConcept C185592680 @default.
- W2146849730 hasConcept C193042331 @default.
- W2146849730 hasConcept C202751555 @default.
- W2146849730 hasConcept C21951064 @default.
- W2146849730 hasConcept C2776256026 @default.
- W2146849730 hasConcept C2777292972 @default.
- W2146849730 hasConcept C2777752112 @default.